ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
The Connection Between Areas in the Brain of Blind Patients

This study has been completed.

Sponsored by: National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00001926
  Purpose

The purpose of this study is to test the belief that specific areas of the brain are connected differently in blind patients than patients with sight. In addition, the study will examine the different anatomical connections between brain areas of patients who became blind early in life versus patients who became blind later.


Condition Intervention
Blindness
Brain Mapping
Healthy
Drug: O15
Device: Cadwell rTMS

U.S. FDA Resources

Study Type:   Observational
Official Title:   Connectivity of Occipital and Somatosensory Cortical Areas in Blind Subjects

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment:   45
Study Start Date:   April 1999
Estimated Study Completion Date:   November 2003

Detailed Description:

The purpose of this protocol is to test the hypothesis that the anatomical connectivity of occipital and somatosensory areas in early blind subjects differs from that in subjects who became blind later in life and from that in sighted volunteers.

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

INCLUSION CRITERIA:

Subjects with late blindness.

Subjects with early blindness.

Sighted volunteers.

Age between 18 and 65 years.

EXCLUSION CRITERIA:

Subjects with personal or family history of seizures or other neurological or demyelinating disorders.

Pregnant women tested after urine pregnancy test.

Subjects with metal in the cranium except mouth.

Subjects with intracardiac lines and implanted medication pumps.

Subjects with increased intracranial pressure as evaluated by clinical means.

Subjects with cardiac pacemakers.

Intake or neuroleptics.

Subjects with blindness secondary to degenerative CNS diseases.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001926

Locations
United States, Maryland
National Institute of Neurological Disorders and Stroke (NINDS)    
      Bethesda, Maryland, United States, 20892

Sponsors and Collaborators
  More Information


Publications:

Study ID Numbers:   990031, 99-N-0031
First Received:   November 3, 1999
Last Updated:   March 3, 2008
ClinicalTrials.gov Identifier:   NCT00001926
Health Authority:   United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Plasticity  
Magnetic Stimulation  
PET  
Blind
Braille
Transcranial Magnetic Stimulation

Study placed in the following topic categories:
Signs and Symptoms
Sensation Disorders
Vision Disorders
Eye Diseases
Neurologic Manifestations
Healthy
Blindness

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on November 30, 2008




Links to all studies - primarily for crawlers